MCM
RDY icon

Munder Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Munder Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-9,430
Closed -$81K – 666
2014
Q2 		$81K Hold
9,430
– – ﹤0.01% 605
2014
Q1 		$83K Sell
9,430
-1,415
-13% -$12.3K ﹤0.01% 600
2013
Q4 		$89K Buy
+10,845
New +$85.8K ﹤0.01% 590

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Munder Capital Management's RDY Position: Q3 2014 in Review

Munder Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2014, closing a stake of 9,430 shares — an estimated $81K sold.

Munder Capital Management first reported a position in RDY in Q4 2013 and held it in 3 quarters. The position peaked at $89K in Q4 2013. 159 funds tracked by Wall St. Rank hold RDY as of Q3 2014.

  • Munder Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2014 after selling out during the quarter.
  • Munder Capital Management sold 9,430 Dr. Reddy's Laboratories shares in Q3 2014, an estimated $81K.
  • Munder Capital Management first reported a position in Dr. Reddy's Laboratories in Q4 2013 and held it in 3 quarters.
  • Munder Capital Management's Dr. Reddy's Laboratories position peaked at $89K in Q4 2013.
  • 159 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2014.

Based on Munder Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.